Schedule 13G ownership disclosure
Orexigen Theraptcs
Security class unavailable · CUSIP: 686164302
Event date: 2017-11-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,600,000
- Percent of class
- 8.5400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-17-004469
- Form type
- SC 13G
- Filer
- Man Group plc
- CIK
- CIK 1637460
- Filed
- Dec 01, 2017
- Reporting period
- Nov 27, 2017
- Description
- Schedule 13G beneficial ownership